retatrutide phase 2 results 2024 2025 The MariTide trial of once-monthly maridebart cafraglutide, a peptide–antibody conjugate, showed substantial weight reduction in participants with obesity with or without type 2 diabetes. Full trial and Research Summary Retatrutide: The Triple Agonist That's
Description
Not because the drug is coming for your muscle, but because its the cheapest insurance youll ever buy
Canceling Hims & Hers is straightforward
Activation of Glucagon-like Peptide-1 Receptor Inhibits Tumourigenicity and Metastasis of Human Pancreatic Cancer Cells via PI3K/Akt Pathway
Retatrutide is generally given via a weekly injection (just like most other GLP-1)
doi:10.1016/j.ijcard.2018.09.061 157
As seen below, the change in the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS), reflecting physical limitations and symptoms, nearly doubled
